Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Neoplasms, Metastasis
Interventions: OTHER: This study is non-interventional study, so this section is not applicable.
Sponsor: GlaxoSmithKline